Feb 4, 2026
The House of Lords Public Services Committee has published its report concluding its medicines security inquiry. They argued that it is vital that the UK has strong, resilient medicine supply chains and emphasised the need for clear, proactive leadership. The report...
Jan 30, 2026
Aspirin has been added to the government’s ‘No Export’ list and to the list of concessions meant to help pharmacies break even when they dispense this hard to get product. Prices are rising in the UK market, so we thought we’d have a look at...
Jan 7, 2026
To start the year off with a bang, we thought we’d compare the generic product prices we get from our Pharmacy and Dispensing Doctor data suppliers with the Drug Tariff for each product. This obviously excludes some products where there is no Drug Tariff...
Oct 16, 2025
Repaglinide is an oral antihyperglycemic agent used for the treatment of non-insulin-dependent diabetes mellitus. The average market price for this medicine normally hovers around the £5 mark but in late 2019 the drug tariff started to come down from over £10.42...
Oct 13, 2025
Check out the latest UK Price Watch article in the Generics Bulletin for analysis and insight on September’s product launches, the biggest risers, the biggest fallers and the fastest movers…. with market data provided by WaveData. Dave Wallace editor at Generics...
Sep 24, 2025
At last week’s EMIG Quarterly meeting Donal Markey, Assistant director of Programmes, Transformation and Performance, said that the Irish health service had been reorganised just once while England’s NHS had been reorganised 7 times. As we are in our Silver...
